VX-445

FDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup
Endpoints
Tue, 08/20/19 - 12:43 pm
Vertex Pharmaceuticals
FDA
cystic fibrosis
VX-445
tezacaftor/ivacaftor
Vertex files cystic fibrosis triple therapy with FDA
PM Live
Tue, 07/23/19 - 07:50 pm
Vertex Pharmaceuticals
FDA
cystic fibrosis
VX-445
5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit
Motley Fool
Wed, 06/12/19 - 09:45 am
Vertex Pharmaceuticals
VX-445
tezacaftor/ivacaftor
AbbVie
upadacatinib
Daiichi Sankyo
trastuzumab deruxtecan
Celgene
liso-cel
Novartis
LY3298176
Vertex to submit VX-445, Tezacaftor and Ivacaftor regimen for global regulatory approvals in cystic fibrosis
Pharmaceutical Business Review
Fri, 05/31/19 - 09:46 am
Vertex Pharmaceuticals
VX-445
tezacaftor
ivacaftor
cystic fibrosis
Vertex Faces Choice After Second CF Drug Combo Succeeds in Phase 3
Xconomy
Wed, 03/6/19 - 11:42 am
Vertex Pharmaceuticals
cystic fibrosis
clinical trials
VX-445
Symdeko
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
CP Wire
Thu, 09/6/18 - 09:35 am
Vertex Pharmaceuticals
VX-659
VX-445
correctors
cystic fibrosis
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
Thu, 09/6/18 - 09:20 am
Vertex Pharmaceuticals
VX-659
VX-445
cystic fibrosis
Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market
Forbes
Thu, 02/1/18 - 09:32 am
Vertex Pharmaceuticals
cystic fibrosis
Kalydeco
VX-659
VX-445